Nature Communications (Sep 2021)

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

  • Tingting Li,
  • Wenhui Xue,
  • Qingbing Zheng,
  • Shuo Song,
  • Chuanlai Yang,
  • Hualong Xiong,
  • Sibo Zhang,
  • Minqing Hong,
  • Yali Zhang,
  • Hai Yu,
  • Yuyun Zhang,
  • Hui Sun,
  • Yang Huang,
  • Tingting Deng,
  • Xin Chi,
  • Jinjin Li,
  • Shaojuan Wang,
  • Lizhi Zhou,
  • Tingting Chen,
  • Yingbin Wang,
  • Tong Cheng,
  • Tianying Zhang,
  • Quan Yuan,
  • Qinjian Zhao,
  • Jun Zhang,
  • Jason S. McLellan,
  • Z. Hong Zhou,
  • Zheng Zhang,
  • Shaowei Li,
  • Ying Gu,
  • Ningshao Xia

DOI
https://doi.org/10.1038/s41467-021-25997-3
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Antibodies (Abs) targeting highly conserved epitopes are important tools against emerging virus variants. Here, the authors characterize Abs that recognize a cryptic epitope in the receptor-binding domain of SARS-CoV-2 spike that is well conserved and show that these Abs can neutralize several variants of concerns.